Daniele Morpurgo, Riccardo Serenthà, et al.
International Immunology
Gilbert’s syndrome (GS) is a mild liver condition, characterized by impaired ability to process bilirubin.1 Its prevalence ranges from 0.5% to 10%, depending on the population.2 Studies have shown that individuals with GS have a lower risk of atherosclerotic cardiovascular disease (ASCVD).3–5 However, no systematic comparison across different subgroups has been conducted. Using a large electronic health record (EHR), we measured the effect of GS on incident ASCVD events by age, race, and sex subgroups. Our findings highlight protection effect of GS varies among different subgroups.
Daniele Morpurgo, Riccardo Serenthà, et al.
International Immunology
Toby G. Rossman, Ekaterina I. Goncharova, et al.
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Young H. Kwark, Miroslav Kotzev, et al.
IMS 2011
John K. Kastner, Chandler R. Dawson, et al.
Journal of Medical Systems